Latest

GSK reports improved outlook despite US drug tariffs
GSK reports improved outlook despite US drug tariffs
Business and Economy
by  AFP

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, despite US tariffs, after sales of its cancer drugs jumped in the second quarter. Group sales increased one percent to £8 billion, helped by a 36 percent increase in cancer treatments that offset falls for other drugs, including for influenza.

Hermes confirms outlook for rising sales in 2025
Hermes confirms outlook for rising sales in 2025
Business and Economy
by  AFP

French luxury group Hermes confirmed Wednesday its outlook for full-year sales growth as it turned rising revenue for all parts of the world in the first half despite global economic uncertainty. "In the medium-term, despite the economic, geopolitical and monetary uncertainties around the world, the group confirms an ambitious goal for revenue growth at constant exchange rates," it said.